Mateusz Brzeziński

Mateusz Brzeziński is a financial and technology journalist at Bez-kabli.pl, covering stocks, artificial intelligence, semiconductors and global market developments. He graduated from the Prague University of Economics and Business in the Czech Republic and previously worked in financial analysis before moving into business journalism. His reporting focuses on the companies, technologies and market trends shaping the global economy.

Collective Acquisition Corp. II Stock Sits Below $10 — The SPAC Test Investors Can’t Ignore
····

Collective Acquisition Corp. II Stock Sits Below $10 — The SPAC Test Investors Can’t Ignore

Collective Acquisition Corp. II units were sitting just below their $10 IPO price before Tuesday’s regular Nasdaq session, a small discount that leaves the newly listed blank-check company trading more like cash than a bet on a named business. The Nasdaq-listed units, ticker CAIIU, last showed $9.975 at 4:30 p.m. EDT on Monday, according to StockLight. Nasdaq regular trading runs from 9:30 a.m. to 4 p.m. Eastern, with premarket trading beginning at 4 a.m., a window that often has thinner liquidity and wider price moves.
June 2, 2026
Hotel101 Stock Faces Pre-Nasdaq Pressure as Madrid Prepares for Launch
····

Hotel101 Stock Faces Pre-Nasdaq Pressure as Madrid Prepares for Launch

Hotel101 Global Holdings Corp. last traded at $5.55 before the regular Nasdaq session Tuesday, down from all the LSEG closing prices reported last week. Shares have had little volume and dropped after the company’s Madrid update. The group’s own website listed closes from $5.85 to $6.02 for May 26-29. Pre-market trading was underway early, ahead of Nasdaq’s opening bell, but the regular session wouldn’t start for hours. Nasdaq’s main market is open from 9:30 a.m. to 4 p.m. Eastern. June 2 is not shown on Nasdaq’s list of U.S. equity market holidays for 2026.
June 2, 2026
Genprex trades under $1 as ASCO results land
····

Genprex trades under $1 as ASCO results land

Genprex Inc. stock stayed close to Monday’s low before the next U.S. trading session, keeping the Nasdaq Capital Market gene therapy name below $1. Investors were watching new lung-cancer biomarker data, while funding remained a concern. June 2 isn’t on the Nasdaq's 2026 market holiday schedule. GNPX was last quoted at $0.7501, about 4% lower than its previous close. That puts the company’s market cap near $7.9 million. Monday’s session saw the stock drop 3.77%, opening at $0.78, hitting a high of $0.79, and bottoming at $0.72 before closing at $0.75. About 401,000 shares changed hands.
June 2, 2026
UK & AU Stock Market Today: Live Updates 02.06.2026
···

UK & AU Stock Market Today: Live Updates 02.06.2026

LIVEMarkets rolling coverageStarted: June 2, 2026, 4:00 AM EDTUpdated: June 3, 2026, 3:59 AM EDT ASX Lithium Sector Overview: Producers, Developers, and Explorers on ASX 200 June 3, 2026, 3:59 AM EDT. The ASX lithium sector comprises producers, developers, and explorers listed on the ASX 200 index, reflecting the growing demand for lithium in energy storage and electric vehicles. This sector includes companies at various stages, from exploration to production. Investors should note the sector’s volatility and evolving market dynamics influenced by global supply chains and technological advancements. Market participants are advised to conduct thorough due diligence and seek professional
June 2, 2026
Journey Medical Shares Drop—DERM’s 2026 Outlook Hinges on Emrosi Trial
····

Journey Medical Shares Drop—DERM’s 2026 Outlook Hinges on Emrosi Trial

Journey Medical Corp was down 3.5% at $6.09 late Monday, putting the company's market cap around $166 million. The Scottsdale-based maker of dermatology drugs trailed the SPDR S&P Biotech ETF, which slipped 2.2%. No new company statement has landed in the past two days. Journey’s investor page still shows the last update as May 19, when it flagged its slot at A.G.P.’s Annual Virtual Healthcare Conference. Before that, the site posted Journey’s May 13 Q1 earnings.
June 2, 2026
WhiteFiber Stock Jumps as AI Data-Center Bet Heats Up Again
····

WhiteFiber Stock Jumps as AI Data-Center Bet Heats Up Again

WhiteFiber Inc shares rose about 6% in late Nasdaq trading on Monday, rebounding from an intraday low as investors bought back into smaller artificial-intelligence infrastructure names. The stock last traded at $31.56 at 5:38 p.m. EDT, after opening at $29.02 and touching $32.00, giving the company a market value of about $1.21 billion. The move matters because WhiteFiber is still being judged less like a mature data-center company and more like a capital-hungry AI buildout story. It owns high-performance computing, or HPC, data centers — clustered computing power used for heavy AI workloads — and provides cloud-based GPU services, using graphics-processing chips that train and run AI models.
June 2, 2026
PRF Technologies Shares Drop a Third After AI Solar Jump
····

PRF Technologies Shares Drop a Third After AI Solar Jump

PRF Technologies Ltd. plunged 32.7% to end Monday at $2.02, reversing some of last week’s big jump on its artificial intelligence solar-software pitch. Shares moved in a $1.87 to $2.35 range, with volume topping 3 million. StockAnalysis put the company’s market cap near $1.75 million. The decline was notable, breaking from the general market trend. SPY and QQQ, both ETFs linked to big U.S. stocks and Nasdaq-type growth names, were a bit higher late Monday.
June 1, 2026
Solstice Advanced Materials Moves Ahead of Sector
·····

Solstice Advanced Materials Moves Ahead of Sector

Solstice Advanced Materials shares gained Monday afternoon, with the stock up 0.9% at $84.95 as of 2:49 p.m. EDT. Solstice traded between $82.93 and $85.13. The move put Solstice ahead of the broader materials group, as investors seemed to focus more on nuclear and electronic-materials growth than on margin pressures. Timing is key here. Solstice is set to hold a nuclear-business webinar on June 4, which will let the Honeywell spin-off talk details on one of its quicker growth areas. Investors on record as of May 27 will also pick up a $0.075 per share dividend when the payout lands June 10.
June 1, 2026
Intchains shares move higher with spotlight on Ethereum staking push
····

Intchains shares move higher with spotlight on Ethereum staking push

Intchains Group Limited shares traded higher in the U.S. Monday, beating out some other crypto-related stocks as buyers came back to the small-cap blockchain firm before its investor event set for later this week. American depositary shares were up 8.4% at $0.90, trading on volume of around 160,500 shares. The U.S.-traded certificates opened at $0.8751 and changed hands between $0.8119 and $0.90 so far.
June 1, 2026
Neogen Stock Slips as Food-Safety Turnaround Faces a Harder Test
····

Neogen Stock Slips as Food-Safety Turnaround Faces a Harder Test

Neogen Corp shares edged lower in Monday afternoon Nasdaq trading, lagging a firmer technology-led tape as investors kept the food- and animal-safety testing company in a holding pattern before its next operating update. The stock traded at $8.94, down about 0.4%, after moving between $8.75 and $9.15; its market value was about $1.94 billion, market data showed. The move was small. The message was not. Neogen is still being judged less on the day’s market mood than on whether it can turn Food Safety growth, cost cuts and a planned portfolio exit into steadier earnings.
June 1, 2026
Vistagen Stock at 63 Cents: The June Trial Readout Traders Are Watching
····

Vistagen Stock at 63 Cents: The June Trial Readout Traders Are Watching

Vistagen Therapeutics shares were little changed before the regular Nasdaq open on Monday, quoted around $0.63, as investors looked past a quiet weekend and toward a trial-data window that could set the next move in the small biotech stock. U.S. equity markets were on a normal schedule; Nasdaq’s 2026 calendar lists the next June closure as Juneteenth on June 19. The timing matters. Vistagen, valued at about $26.6 million, is heading into June with its lead anxiety drug still carrying most of the equity story, while the SPDR S&P Biotech ETF, a broad gauge of biotech risk appetite, was modestly firmer before the open.
June 1, 2026
Core Scientific Stock Slips Before the Open as Its AI Data-Center Bet Faces a June Test
····

Core Scientific Stock Slips Before the Open as Its AI Data-Center Bet Faces a June Test

Core Scientific shares fell about 3.2% to $26.85 in early pre-market trading on Monday, a softer start for a stock that investors have been treating as a bet on artificial-intelligence data-center demand as much as on bitcoin mining. The move put the company’s market value at about $8.67 billion before the regular U.S. session. The timing matters. Nasdaq’s 2026 holiday calendar lists no market closure for June 1, with the next scheduled full closure on June 19 for Juneteenth, so Monday is a normal trading day. Pre-market trading, the session before the main exchange day starts, can be thin and more volatile than regular trading.
June 1, 2026
Kraft Heinz slips after streak; eyes on Monday’s open
····

Kraft Heinz slips after streak; eyes on Monday’s open

Kraft Heinz edged lower in early U.S. trading Monday, after breaking a six-session streak last Friday. The stock was at $23.95 before the bell at 8:00 a.m. ET, down 0.25% from its Friday close of $24.01, brokerage data showed. Kraft Heinz’s new turnaround efforts are drawing attention from investors as the company tries to spark a rebound after struggling with weak demand and pressure on margins. The Nasdaq is set for a regular open at 9:30 a.m. ET. June 1 is not listed as a holiday on the 2026 Nasdaq market schedule.
June 1, 2026
Alto Ingredients Pops in June as Biofuel Credits Rally
····

Alto Ingredients Pops in June as Biofuel Credits Rally

Alto Ingredients Inc. opens Monday’s U.S. trade after shares jumped 4.61% Friday to finish at $5.45 with around 3.1 million shares changing hands. That’s ahead of the S&P 500, which was up 0.22%, and the Nasdaq Composite, up 0.20%. The rally now faces a normal trading day instead of a quiet holiday period. Nasdaq runs pre-market, regular, and after-hours trading, with the main open at 9:30 a.m. ET and the close at 4:00 p.m. ET. June 1 isn’t a listed holiday. Nasdaq’s next closure is Juneteenth on June 19.
June 1, 2026
Werewolf Therapeutics Stock Stalls While HOWL Holds for Strategic Update
····

Werewolf Therapeutics Stock Stalls While HOWL Holds for Strategic Update

Werewolf Therapeutics stock traded near 45 cents Monday morning, holding close to its 52-week low on Nasdaq. Investors watching for updates on the company’s ongoing strategic review. Shares were flat in early trading, putting the company’s market cap near $22 million. The timing here is important because the most recent company-specific filing before this week wasn’t a trial update—it was an insider sale. A Form 4 filed after the bell Friday showed entities tied to director Luke Evnin dumped a total of 141,106 Werewolf shares between May 27 and May 29, using a Rule 10b5-1 plan, which lets insiders sell stock on a schedule.
June 1, 2026
Aveanna Healthcare draws attention after debt repricing and Friday dip
····

Aveanna Healthcare draws attention after debt repricing and Friday dip

Aveanna Healthcare Holdings Inc. shares are back in focus as premarket action opens Monday, following a down day Friday. Investors are watching a standard shareholder vote, recent debt repricing, and an investor presentation set for Tuesday. Aveanna finished at $7.17 on May 29, a drop of 2.18%, based on its historical pricing chart. Timing is key here. Nasdaq’s premarket was active at the dateline, but normal hours are 9:30 a.m. to 4:00 p.m. Eastern. June 1 isn’t marked on Nasdaq’s 2026 U.S. holiday list.
June 1, 2026
Reynolds Consumer Products Faces Key Cost Issue at Start of June
····

Reynolds Consumer Products Faces Key Cost Issue at Start of June

Reynolds Consumer Products Inc. is set to open Monday at $21.67, after sliding 1.95% on Friday. That loss capped a short Memorial Day week where the stock ended down about 0.6% from the previous Friday’s close. With not much in the way of new company news, the setup is now in focus. The main thing for investors is whether they reward Reynolds for a strong Q1 or keep the pressure on the stock as June gets underway with aluminum and resin costs still up.
June 1, 2026
ArcBest Trades Close to 52-Week High as Investors Wait for Freight Recovery
····

ArcBest Trades Close to 52-Week High as Investors Wait for Freight Recovery

ArcBest Corporation is trading near its 52-week high as U.S. markets open Monday, with investors watching to see how far ahead of earnings the stock can run on freight recovery hopes. Shares were changing hands at $136.69 for a market cap close to $3.05 billion, just under the 52-week high of $138.00, according to MarketWatch. New York markets were still closed in premarket hours. Nasdaq’s calendar for 2026 does not show June 1 as a holiday. U.S. exchanges, including Nasdaq, usually trade from 9:30 a.m. to 4:00 p.m. ET on weekdays when there is no holiday.
June 1, 2026
Geospace Rallied in Holiday Week; Monday Test Still Looms
····

Geospace Rallied in Holiday Week; Monday Test Still Looms

Geospace Technologies Corp. finished the shortened week up, even after dropping 4.49% Friday to close at $8.30. Shares traded between $8.21 and $8.57 on the day, with about 133,000 shares changing hands. For the week, the seismic and smart-water technology stock climbed about 2.5% from last Friday’s $8.10 close. It's relevant now because this move followed a tough financial update from earlier in May, not any new catalyst from the company. The market is weighing Geospace's cost reductions and work on new projects against ongoing weak demand in smart-water and continued cash burn.
June 1, 2026
TScan Therapeutics hangs around $1.08; eyes on next week
····

TScan Therapeutics hangs around $1.08; eyes on next week

TScan Therapeutics heads into June as investors wait for the next clinical update. Shares ended Friday at $1.08, with trading volume light ahead of the weekend and U.S. markets closed. The stock moved between $1.04 and $1.13 through the shortened week, historical data from the company showed. TScan is flagging early data for Cohort C in its ALLOHA Phase 1 blood-cancer trial for the second quarter and also says it wants to start a Phase 3 trial of TSC-101 in that same quarter. A Phase 3 trial is late-stage and usually backs a regulatory filing.
May 31, 2026
1 … 26 27 28 29 30 … 80